Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
Tax payers paid to develop remdesivir but will have no say when Gilead sets the price
27 May 2020 - Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus ...
Posted by Michael Wonder on 28 May 2020
Australia avoids 'risky business' of coronavirus vaccine sweepstakes
27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...
Posted by Michael Wonder on 27 May 2020
Prospective dialogue between developers and regulators makes for better evidence generation
27 May 2020 - EMA, in collaboration with other parties, has recently published two scientific articles outlining the importance of ...
Posted by Michael Wonder on 24 May 2020
U.S. is ahead of China in vaccine race, former FDA chief says
24 May 2020 - Data on Chinese vaccines in clinical development “didn’t look overwhelmingly strong,” Scott Gottlieb said. ...
Posted by Michael Wonder on 21 May 2020
Drug innovation is back in fashion
21 May 2020 - Big pharma is no longer the villain. ...
Posted by Michael Wonder on 20 May 2020
Europe falls behind U.S. in funding coronavirus vaccine and securing access
19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc ...
Posted by Michael Wonder on 18 May 2020
Australia must work to avoid 'vaccine nationalism', former top bureaucrat warns
18 May 2020 - A former top bureaucrat has warned the international race to develop a vaccine against the novel ...
Posted by Michael Wonder on 18 May 2020
COVID-19 vaccine frontrunners emerge as rollout debate rages
18 May 2020 - Governments and drug makers are weighing how to roll out coronavirus vaccines, including reserving the first ...
Posted by Michael Wonder on 18 May 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #6
15 May 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 14 May 2020
Russia says search for a coronavirus treatment should not be a medical ‘arms race’
14 May 2020 - Russia’s sovereign wealth fund has been funding Russian development and production of the drug favipiravir, an anti-influenza ...
Posted by Michael Wonder on 13 May 2020
Gilead’s remdesivir tested with other drugs to fight COVID-19
13 May 2020 - Researchers are looking to find a more potent coronavirus-fighting cocktail. ...
Posted by Michael Wonder on 12 May 2020
COVID-19 update: FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
11 May 2020 - Today, the U.S. FDA took important actions to help accelerate the development of prevention and treatment options ...
Posted by Michael Wonder on 05 May 2020
World leaders donate to COVID-19 vaccine funding drive
5 May 2020 - Experts says $20 billion needed to vaccinate global population. ...
Posted by Michael Wonder on 05 May 2020
Bill Gates donates $10 million to Australian trial of immune-boosting vaccine
5 May 2020 - Bill Gates has donated $10 million to an Australian trial of a vaccine that researchers hope ...
Posted by Michael Wonder on 05 May 2020
COVID-19: Australia’s pledge to $12 billion virus fight, WHO issues vaccine warning
5 May 2020 - Scott Morrison has promised more than $352 million as part of a global coronavirus vaccine fundraiser, but ...